Cannabinoids As Drugs – Latest Updates

On-Demand Schedule Wed, June 19, 2024 - Wed, June 26, 2024
Duration 90 Mins
Webinar ID IQW19I0938
Level Basic & Intermediate & Advanced

  • What are Cannabinoids
  • Legal Status of Cannabinoids
  • How was Epidolex approved
  • The current marketing of CBD
  • Research on Cannabinoids
  • Possible future Cannabinoids

Overview of the webinar

This webinar will discuss the current status of cannabinoids as medical products in the United States. The focus will be on what we can learn from the FDA approval of Epidolex (Cannabidiol) oral solution 100 mg/mL. How to obtain research information will be presented. The current market for Cannabidiol (CBD) in the United States will also be discussed. This information may be useful in predicting the future of cannabinoids in the United States. The legality of foods containing CBD will be considered.

Who should attend?

  • Pharmaceutical Executives
  • Pharmaceutical Research and Development
  • Pharmaceutical Regulatory Affairs
  • Food Research and Development
  • Food Executive
  • Quality Professionals
  • Regulatory Compliance Officer

Why should you attend?

This training will provide valuable information to those who decide which products to pursue and those who develop them or submit their applications. The status of Cannabinoids in the United States is changing rapidly. This webinar will attempt to discuss the latest FDA and market information about them.

Faculty - Dr.Loren Gelber

Dr. Loren Gelber has more than 40 years in the pharmaceutical industry. She spent her first ten years at FDA, followed by 20 years in Regulatory Affairs and Compliance at various pharmaceutical companies, and the last ten years as a Regulatory Compliance Consultant. During this time she was a member of various groups and committees that worked on many compliance issues. She has published a number of papers and delivered various seminars and talks. Dr. Gelber holds a BA in Biology from Brandeis University, an MS in Chemistry from Brooklyn Polytechnic Institute (now part of NYU) and a PhD in Medicinal Chemistry from Northeastern University School of Pharmacy and Allied Health Professions. She current resides in Charlotte, NC.


Refund / Cancellation policy
For group or any booking support, contact: